Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis
- PMID: 21504996
- DOI: 10.1136/gut.2010.235473
Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis
Abstract
Background: Patients with advanced cirrhosis often develop a hyperdynamic circulation with central hypovolaemia. The events that initiate the systemic haemodynamic abnormalities and the coupling of these factors to splanchnic haemodynamics are still unclear. Objective On the basis of a large population of patients with cirrhosis to identify splanchnic and clinical characteristics associated with the development of the hyperdynamic circulation and survival.
Methods: We included 410 patients with cirrhosis. In all patients, a full haemodynamic investigation was performed. The data were analysed using regression analyses, principal components analyses, and Cox proportional hazards analyses.
Results: Multivariate regression analyses showed that higher cardiac output was independently associated with higher hepatic venous pressure gradient (HVPG) and higher hepatic blood flow (HBF) (p<0.00001). Higher heart rate was independently associated with presence of ascites and higher HVPG (p<0.0001). Central blood volume and circulation time were independently associated with higher HBF and lower postsinusoidal resistance, respectively (p<0.0001). Systemic vascular resistance was independently associated with lower HVPG (p<0.0001). The final Cox proportional hazards model showed that decreased survival was independently associated with higher age (p=0.003), lower blood haemoglobin concentration (p=0.0006), higher plasma creatinine (p=0.01), higher plasma alkaline phosphatase (p=0.007), lower right atrial pressure (p=0.004), and higher heart rate (p=0.002).
Conclusion: The development of the hyperdynamic circulation and central hypovolaemia are mainly explained by changes in portal pressure and HBF. Together with indicators of liver dysfunction, central hypovolaemia is associated with poorer prognosis.
Comment in
-
Hyperdynamic circulation and portal hypertension: chicken or egg?Gut. 2011 Sep;60(9):1167-9. doi: 10.1136/gut.2011.242511. Epub 2011 May 25. Gut. 2011. PMID: 21613646 No abstract available.
Similar articles
-
Determinants of the renin-angiotensin-aldosterone system in cirrhosis with special emphasis on the central blood volume.Scand J Gastroenterol. 2006 Apr;41(4):451-8. doi: 10.1080/00365520500292962. Scand J Gastroenterol. 2006. PMID: 16635914
-
Splanchnic and systemic haemodynamic response to volume changes in patients with cirrhosis and portal hypertension.Clin Sci (Lond). 1999 May;96(5):475-81. Clin Sci (Lond). 1999. PMID: 10209079
-
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.Gastroenterology. 2007 Aug;133(2):481-8. doi: 10.1053/j.gastro.2007.05.024. Epub 2007 May 21. Gastroenterology. 2007. PMID: 17681169 Clinical Trial.
-
Clinical implications of the hyperdynamic syndrome in cirrhosis.Eur J Intern Med. 2014 Nov;25(9):795-802. doi: 10.1016/j.ejim.2014.09.004. Epub 2014 Sep 20. Eur J Intern Med. 2014. PMID: 25245607 Review.
-
Hepatosplanchnic circulation in cirrhosis and sepsis.World J Gastroenterol. 2015 Mar 7;21(9):2582-92. doi: 10.3748/wjg.v21.i9.2582. World J Gastroenterol. 2015. PMID: 25759525 Free PMC article. Review.
Cited by
-
Cardiac Imaging in Liver Transplantation Candidates: Current Knowledge and Future Perspectives.J Clin Med. 2019 Dec 3;8(12):2132. doi: 10.3390/jcm8122132. J Clin Med. 2019. PMID: 31817014 Free PMC article. Review.
-
Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis.Sci Rep. 2020 Feb 18;10(1):2869. doi: 10.1038/s41598-020-59817-3. Sci Rep. 2020. PMID: 32071351 Free PMC article.
-
Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.World J Gastroenterol. 2014 Nov 14;20(42):15499-517. doi: 10.3748/wjg.v20.i42.15499. World J Gastroenterol. 2014. PMID: 25400435 Free PMC article. Review.
-
Increased EETs participate in peripheral endothelial dysfunction of cirrhosis.Prostaglandins Other Lipid Mediat. 2012 Aug;98(3-4):129-32. doi: 10.1016/j.prostaglandins.2011.12.008. Epub 2012 Jan 10. Prostaglandins Other Lipid Mediat. 2012. PMID: 22245571 Free PMC article.
-
Practice guidance for the use of terlipressin for liver cirrhosis-related complications.Therap Adv Gastroenterol. 2022 May 18;15:17562848221098253. doi: 10.1177/17562848221098253. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 35601800 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical